Prevalence of Prescription Opioids for Nonoperative Treatment of Rotator Cuff Disease Is High

• Váldodahkkit: Jacob Gorbaty, M.D (Dahkki), Susan M. Odum, Ph.D (Dahkki), Meghan K. Wally, M.S.P.H (Dahkki), Rachel B. Seymour, Ph.D (Dahkki), Nady Hamid, M.D (Dahkki), Joseph R. Hsu, M.D (Dahkki), Michael Beuhler, M.D (Dahkki), Michael J. Bosse, M.D (Dahkki), Michael Gibbs, M.D (Dahkki), Christopher Griggs, M.D (Dahkki), Steven Jarrett, Pharm.D (Dahkki), Daniel Leas, M.D (Dahkki), Tamar Roomian, M.S., M.P.H (Dahkki), Michael Runyon, M.D (Dahkki), Animita Saha, M.D (Dahkki), Bradley Watling, M.D (Dahkki), Stephen Wyatt, D.O (Dahkki), Ziqing Yu, M.S (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Elsevier, 2021-04-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Purpose: To quantify the prevalence of opioid and benzodiazepine prescriptions for patients with rotator cuff disease across a large health care system and to describe evidence-based risk factors for opioid use within this population. Methods: We conducted a retrospective cohort study at a major hea...